KPV 20mg — Vial Spec, Reconstitution Math & COA

KPV 20mg Lyophilized Peptide Specification & Primary Application

The KPV 20mg vial contains a highly purified, lyophilized tripeptide consisting of the amino acid sequence Lysine-Proline-Valine (Lys-Pro-Val). Representing the C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone (alpha-MSH), KPV retains potent anti-inflammatory properties without activating classical melanocortin receptors responsible for pigmentary changes. The 20mg mass configuration is specifically formatted for high-volume biomedical research, enabling investigators to execute multi-plate cellular assays, continuous infusion designs, or large-cohort preclinical animal trials without requiring frequent inter-vial reconstitution.

While PX1 Research maintains standard KPV 10mg vials for small-to-medium assay series, the 20mg specification is made available for high-throughput screening environments, institutional projects, and specialized custom fills. Researchers sourcing from the comprehensive all-peptides catalog utilize this concentration to establish consistent master stock solutions, reducing lot-to-lot variance across extended experimental timelines. Every 20mg fill undergoes identical ultra-purification, mass spectrometry sequencing, and endotoxin quantitation to ensure uncompromising experimental reproducibility.

Molecular Structure and Preclinical Anti-Inflammatory Mechanisms

At the structural level, KPV is a tripeptide with a molecular formula of C16H30N4O4 and a molecular weight of approximately 342.44 g/mol. Despite its minimalist structure, preclinical studies demonstrate that KPV acts as a potent modulator of cellular inflammatory cascades. The primary mechanism of action involves the inhibition of Nuclear Factor kappa B (NF-kB) translocation into the nucleus. By preventing NF-kB nuclear localization, KPV downregulates the transcription of pro-inflammatory cytokines including TNF-alpha, IL-1 beta, and IL-6 within epithelial cells and immune populations.

In vitro cell culture experiments utilizing intestinal epithelial cells (e.g., Caco-2 monolayers) and macrophages indicate that KPV enters cells via the peptide transporter PepT1 (SLC15A1). Once internalized, KPV interacts directly with intracellular signaling proteins to suppress inflammatory signaling pathways. Preclinical models of inflammatory bowel disease (IBD), such as dextran sulfate sodium (DSS)-induced colitis in rodents, demonstrate that administration of KPV attenuates histological damage, preserves mucosal barrier integrity, and reduces local leukocyte infiltration. These anti-inflammatory mechanisms operate independently of systemic immunosuppression, highlighting KPV as a key subject in gut barrier research.

Reconstitution Math for a 20mg KPV Vial: 1mL, 2mL, and 3mL Dilutions

Reconstitution of a 20mg lyophilized KPV vial requires precise volumetric calculation to achieve target concentrations for laboratory dosing or cell culture media spiking. When working with a 20mg mass, adding 1.0 mL of sterile diluent (such as Bacteriostatic Water or sterile PBS) yields a final concentration of 20 mg/mL (20 µg/µL). This high concentration is ideal for creating concentrated stock solutions intended for subsequent serial dilution.

If a 2.0 mL volume of diluent is introduced to the 20mg vial, the resulting solution concentration is 10 mg/mL (10 µg/µL). Adding 3.0 mL of diluent dilutes the mixture to approximately 6.67 mg/mL (6.67 µg/µL). For custom target concentrations or non-standard diluent volumes, researchers should utilize our interactive reconstitution-calculator to eliminate math errors during laboratory preparation.

When performing reconstitution, introduce the solvent slowly along the glass wall of the vial to minimize shear force and bubble formation. Gentle swirling is recommended until complete dissolution is achieved; vortexing should be avoided to prevent structural degradation of the tripeptide. All reconstitution steps must be performed inside a certified laminar flow hood to maintain sterility.

Aliquot Strategy and Degradation Prevention in High-Concentration Stock Solutions

Because a 20mg mass yields a substantial quantity of working reagent, preparing stock aliquots is critical to prevent peptide degradation caused by repeated freeze-thaw cycles. Subjecting reconstituted KPV to multiple temperature shifts promotes molecular aggregation and chemical cleavage, compromising the stability and biological activity of the tripeptide. Once reconstituted, stock solutions should be divided into single-use microcentrifuge tubes calibrated to the specific volumetric needs of upcoming experimental runs.

Aliquots should be frozen immediately at -20°C for intermediate storage (up to 3 months) or -80°C for long-term preservation (up to 12 months). Reconstituted KPV stored at standard refrigeration temperatures (2°C to 8°C) should be utilized within 7 to 14 days, provided a sterile, preserved diluent such as 0.9% benzyl alcohol bacteriostatic water was used. For serum-free cell culture experiments where preservatives are contraindicated, reconstitution in sterile USP-grade saline or PBS must be followed by immediate use or instant deep-freezing.

Lot-Matched Certificate of Analysis (COA) & Quality Verification

PX1 Research enforces strict quality control standards for every manufactured peptide lot. Every batch of KPV—whether formulated in standard 10mg vials or custom 20mg runs—undergoes dual verification via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). The resulting lot-matched coa provides verifiable proof that the peptide achieves a minimum purity standard of 98.0%.

In addition to purity and identity testing, PX1 Research subjects all research compounds to rigorous endotoxin testing using Chromogenic Reagent Assays (LAL testing) in an ISO 17025 accredited laboratory environment. Maintaining low endotoxin levels (<0.05 EU/mg) is imperative for preclinical research, as bacterial endotoxins introduce confounding inflammatory signals that invalidate sensitive cytokine suppression assays. Researchers can review, verify, and download lot-matched COAs directly from our online database prior to initiating experimental protocols.

Evaluating Fill Sizes: KPV 20mg vs. KPV 10mg Formulations

Choosing between a 20mg vial and smaller formats like the standard KPV 10mg depends primarily on experimental design, subject cohort size, and workflow scale. For smaller exploratory pilot studies, localized in vitro assays, or short-term stability testing, a 10mg vial provides sufficient mass while minimizing waste and stock management overhead.

Conversely, the 20mg format provides a significant efficiency advantage for high-throughput screening platforms, automated liquid handling systems, and multi-week animal studies requiring daily reagent administration. Sourcing 20mg units reduces overall vial handling, decreases container surface interaction loss, and streamlines record-keeping during high-volume research. Institutional laboratories running ongoing programs can explore custom batching and volume pricing through our dedicated wholesale portal.

Comparative Analysis: KPV vs. BPC-157 and Larazotide in Mucosal Barrier Models

In preclinical gastroenterology and epithelial barrier models, KPV is frequently studied alongside other protective research peptides such as BPC-157, TB-500, and Larazotide. Each compound targets distinct aspects of tissue repair and mucosal homeostatic regulation:

While BPC-157 promotes tissue repair primarily through VEGFR2 pathway activation, growth factor upregulation, and focal adhesion kinase activity, KPV operates directly as a potent down-regulator of NF-kB driven inflammatory signaling. Meanwhile, Larazotide acts as a tight junction antagonist targeting zonulin pathway modulation. Combining or comparing these agents in dual-assay models allows researchers to isolate specific mechanisms governing mucosal inflammation, epithelial tight-junction maintenance, and tissue repair.

Storage, Handling, and Stability Protocol

Unreconstituted, lyophilized KPV 20mg vials must be stored in a dark, temperature-controlled environment. For short-term storage (under 30 days), desiccated lyophilized powder remains stable at room temperature (20°C to 25°C) during transit and initial laboratory intake. For long-term preservation, lyophilized vials should be kept at -20°C or -80°C, isolated from light and moisture.

All PX1 Research vials are sealed under an inert argon atmosphere with flip-off aluminum crimp caps to protect the lyophilized cake from oxidation and humidity ingress. Researchers should allow frozen vials to equilibrate to room temperature before removing the cap and injecting diluent; opening a cold vial in ambient air invites condensation, which can destabilize the peptide matrix prior to controlled reconstitution.

Institutional Procurement and Custom Synthesis Services

PX1 Research supports academic institutions, biotechnology firms, and contract research organizations (CROs) with verified chemical standards and flexible fill sizes. If your laboratory requires specific bulk configurations, precise unit masses outside standard catalog offerings, or custom packaging, our team provides specialized fulfillment through our wholesale program.

Every custom or institutional fill maintains the core PX1 differentiators: USA manufacturing, ISO 17025 accredited analytical verification, HPLC/MS purity validation, and same-day dispatch from our California and Arizona distribution hubs. Detailed documentation and analytical raw data are provided with all research shipments to support rigorous regulatory and scientific compliance.